After 30 days, when mice in both the HFD-SY and HFD-WM groups reached the weight range of lean age-matched control mice, treatment was withdrawn and the glucose-lowering efficacy of the interventions was determined by measuring hyperglycaemia, hyperinsulinaemia and insulin resistance
Enhancing GSH synthesis, selenium levels and redox-active selenoproteins, and activating Nrf2 and other antioxidant enzymes will strengthen the cardiovascular antioxidant defense
Common Side Effects The following side effects are usually mild, occur most often early in treatment or when the dose is increased, and gradually subside over time: Nausea, significant loss of appetite (approximately 1224%) Diarrhea or constipation (approximately 1222%) Vomiting (approximately 213%) Rare Side Effects If you experience any of the following symptoms, please consult a doctor immediately: Acute pancreatitis (with persistent, severe abdominal pain radiating to the back) Gallbladder disorders (such as acute right upper abdominal pain caused by gallstones) All medications may cause side effects
Explore how dual GLP-1 & GIP therapy works, what to expect, and how Nexa Vitality supports your weight loss journey